Real World Evidence (RWE) is becoming more and more important not only for clinicians but also for scientific meetings such as the American Society of Hematology (ASH) Annual Meeting. Dr Faith Davies, NYU Langone Hospital, New York, USA, summarises in this video the most important updates regarding Real World Evidence in myeloma presented at …
Speaker: Madiha Iqbal Dr. Madiha Iqbal is an Assistant Professor at the Mayo Clinic in Florida since 2020. Dr. Iqbal also trained at the Mayo…
IACH presents the IACH Multiple Myeloma Academy / cancer, IACH, IACH Multiple Myeloma Academy, multiple myeloma, Myeloma Awareness Month, OncoDaily, Oncology,
Submission Deadline: March 24, 2025 Submission Deadline: March 24, 2025 Submit here Submit here Abstracts for the Congress: Participants who would like to actively participate…
New Drugs in Low-Risk MDS: Where do we Stand? – IACH / cancer, IACH, MDS, OncoDaily, Oncology, Talha Badar
By Mahmoud Marashi, Khalil Al Farsi & 8 more. Treatment options for newly diagnosed multiple myeloma (NDMM) have expanded dramatically over the last two decades,…
Speaker: Gili Kenet Prof. Gili Kenet is a Pediatric Hematologist, Professor and chair of the Haematology department at the Sackler Medical School, Tel Aviv University,…
The ALPINE trial established the superiority of zanubrutinib over ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma; here, we present data…
THe IACH Post Congress Webinar Series, is a concise and informative program designed to keep you up-to-date on the latest advancements in the field. IACH…
Mohamad Mohty: How to perform a high-quality peer review / cancer, Clin Hematol Int, Clinical Hematology International, fight against cancer, Global
Speaker: Karina Wilkerson Karina Wilkerson is the Program Coordinator of the Adult Sickle Cell of Excellence Program at Vanderbilt University Medical Center where she leads…
